ALLMedicine™ Hemoptysis Center

Mar 24th, 2023 - This study aimed to evaluate the socio-demographic, clinical, and laboratory risk factors in hospitalized COVID-19 patients during the first 6 months of the SARS-CoV-2 epidemic. This retrospective hospital-based cross-sectional study included all ...

Mar 23rd, 2023 - A man with chronic obstructive pulmonary disease (COPD) in his mid-60s was admitted for respiratory failure due to multifocal, necrotising pneumonia. Despite initial improvement with antimicrobial therapy, the patient developed hemoptysis and prog...

Mar 22nd, 2023 - Practice Essentials Goodpasture syndrome is an eponym that has been used to describe the clinical entity of diffuse pulmonary hemorrhage (as seen in the images below) and acute or rapidly progressive glomerulonephritis. Goodpasture disease is a te...

Mar 22nd, 2023 - Approach Considerations The three principles of therapy in anti–glomerular basement membrane (anti-GBM) disease are as follows: Rapidly remove circulating antibody, primarily by plasmapheresis Stop further production of antibodies using immunosupp...

Mar 22nd, 2023 - Practice Essentials Goodpasture syndrome is an eponym that has been used to describe the clinical entity of diffuse pulmonary hemorrhage (as seen in the images below) and acute or rapidly progressive glomerulonephritis. Goodpasture disease is a te...

May 7th, 2020 - Hemoptysis, the expectoration of blood, ranges in severity from nonmassive to massive. This publication reviews the literature on the imaging and treatment of hemoptysis. Based on the literature, the imaging recommendations for massive hemoptysis ...

Sep 12th, 2019 - Massive hemoptysis is one of emergency and critical diseases of the respiratory system. The definition of massive hemoptysis has always been different in the literature, which often depends on the quantitative estimation of the amount of hemoptysi...

Aug 3rd, 2010 - Cystic fibrosis (CF) is a recessive genetic disease characterized by dehydration of the airway surface liquid and impaired mucociliary clearance. As a result, individuals with the disease have difficulty clearing pathogens from the lung and experi...

Feb 28th, 2023 - Postoperative pain due to surgical incision may limit lung expansion. After cardiac surgery, all patients receive respiratory therapies, because it is critical to expand lung after surgery to prevent respiratory complications such as lung collapse...

Feb 28th, 2023 - Bronchoscopy is a procedure that is frequently applied in diagnostic or interventional conditions like hemoptysis, tracheobronchial stenosis, malignancy, recurrent lung infections, etc. It is routinely performed under general anesthesia or sedatio...

Feb 21st, 2023 - Chronic obstructive pulmonary disease (COPD) and bronchiectasis are common chronic respiratory diseases in China. COPD is characterized by irreversible lung function decline due to airway inflammation, emphysema and alveolar destruction. Bronchiec...

Feb 10th, 2023 - Patients with pulmonary embolism and aged 18 years or older were enrolled in this study.Patient demographic characteristics(age, sex, department, diagnosis), basic vital signs, symptoms at their admissions (hemoptysis, dyspnea, chest pain, syncope...

Feb 8th, 2023 - Current guidelines for referring cystic fibrosis (CF) patients for lung transplantation, based on clinical and functional resting parameters, are insufficient to predict 3-year mortality. Previous studies have shown that sex, impaired pulmonary fu...

Nov 9th, 2022 - Idiopathic thrombocytopenic purpura (ITP) is an immune-mediated acquired condition affecting both adults and children. 1 Acute ITP is the most common form, which happens in the presence of a precipitant, leading to a drop in platelet counts.

Nov 1st, 2022 - Telisotuzumab vedotin (teliso-V) in combination with erlotinib (Tarceva) induced promising outcomes in patients with advanced, EGFR-mutated, c-MET-positive non–small cell lung cancer (NSCLC) who were contraindicated for surgery or other approved t...

Oct 21st, 2022 - The China National Medical Products Administration’s Center for Drug Evaluation has granted a breakthrough therapy designation to the PD-1/VEGF bispecific antibody, ivonescimab (AK112), for use in combination with chemotherapy in patients with EGF...

Sep 1st, 2022 - The Skill Checkup series provides a quick, case-style interactive quiz highlighting key guidelines- and evidence-based information to inform clinical practice. A 53-year-old woman in the United States, a never-smoker, had been complaining of a dry...

Aug 10th, 2022 - Evolution in the management of cystic fibrosis has led to more patients surviving to adulthood, but data on the trends and comorbidities in adult patients, and the impact of disparities in access to care, have not been explored, according to a new...